Concepts (77)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Liver Transplantation | 6 | 2013 | 1112 | 1.210 |
Why?
|
| Tissue Banks | 2 | 2011 | 55 | 0.500 |
Why?
|
| Water-Electrolyte Balance | 1 | 2014 | 104 | 0.470 |
Why?
|
| Hypernatremia | 1 | 2014 | 33 | 0.460 |
Why?
|
| Tissue Donors | 3 | 2012 | 769 | 0.450 |
Why?
|
| Hyponatremia | 1 | 2014 | 82 | 0.440 |
Why?
|
| Caroli Disease | 1 | 2012 | 5 | 0.430 |
Why?
|
| Sodium | 1 | 2014 | 353 | 0.430 |
Why?
|
| Liver Failure | 1 | 2013 | 140 | 0.410 |
Why?
|
| Brain Death | 1 | 2012 | 53 | 0.410 |
Why?
|
| Donor Selection | 1 | 2012 | 110 | 0.390 |
Why?
|
| Death | 1 | 2012 | 119 | 0.390 |
Why?
|
| Seasons | 1 | 2012 | 340 | 0.380 |
Why?
|
| Cystic Fibrosis | 1 | 2013 | 264 | 0.370 |
Why?
|
| Fellowships and Scholarships | 1 | 2012 | 390 | 0.330 |
Why?
|
| Precision Medicine | 2 | 2011 | 1154 | 0.290 |
Why?
|
| Genome, Human | 2 | 2011 | 1869 | 0.280 |
Why?
|
| Databases, Factual | 1 | 2012 | 2218 | 0.260 |
Why?
|
| Graft Survival | 3 | 2013 | 1062 | 0.250 |
Why?
|
| Patient Selection | 1 | 2011 | 2055 | 0.230 |
Why?
|
| Carcinoma, Hepatocellular | 2 | 2011 | 2027 | 0.210 |
Why?
|
| Internship and Residency | 1 | 2012 | 1375 | 0.200 |
Why?
|
| Kaplan-Meier Estimate | 3 | 2012 | 6207 | 0.160 |
Why?
|
| Transplantation, Homologous | 3 | 2012 | 2843 | 0.150 |
Why?
|
| Liver Neoplasms | 2 | 2011 | 4557 | 0.150 |
Why?
|
| Postoperative Complications | 1 | 2012 | 5542 | 0.150 |
Why?
|
| Databases, Nucleic Acid | 2 | 2011 | 117 | 0.120 |
Why?
|
| Aspergillus fumigatus | 1 | 2013 | 135 | 0.110 |
Why?
|
| Deltaretrovirus Infections | 1 | 2011 | 7 | 0.100 |
Why?
|
| Schools, Medical | 1 | 2013 | 132 | 0.100 |
Why?
|
| Incidence | 2 | 2012 | 5673 | 0.100 |
Why?
|
| Forecasting | 2 | 2011 | 694 | 0.100 |
Why?
|
| Cholestasis, Intrahepatic | 1 | 2012 | 74 | 0.100 |
Why?
|
| Aspergillosis | 1 | 2013 | 246 | 0.100 |
Why?
|
| Living Donors | 1 | 2011 | 171 | 0.100 |
Why?
|
| National Cancer Institute (U.S.) | 1 | 2011 | 211 | 0.100 |
Why?
|
| End Stage Liver Disease | 1 | 2012 | 170 | 0.090 |
Why?
|
| Epigenomics | 1 | 2011 | 266 | 0.090 |
Why?
|
| Fatty Liver | 1 | 2011 | 235 | 0.090 |
Why?
|
| Waiting Lists | 1 | 2011 | 263 | 0.090 |
Why?
|
| Tissue and Organ Procurement | 1 | 2012 | 233 | 0.090 |
Why?
|
| Guidelines as Topic | 1 | 2011 | 383 | 0.080 |
Why?
|
| Hospitals, Pediatric | 1 | 2013 | 773 | 0.080 |
Why?
|
| Databases, Genetic | 1 | 2011 | 745 | 0.080 |
Why?
|
| Body Weight | 1 | 2012 | 1293 | 0.080 |
Why?
|
| Sepsis | 1 | 2013 | 652 | 0.070 |
Why?
|
| Child | 3 | 2013 | 29154 | 0.070 |
Why?
|
| Proportional Hazards Models | 2 | 2012 | 4988 | 0.070 |
Why?
|
| Hepatitis C | 1 | 2011 | 524 | 0.070 |
Why?
|
| Exome | 1 | 2011 | 1239 | 0.070 |
Why?
|
| Cell Transformation, Neoplastic | 2 | 2011 | 2359 | 0.070 |
Why?
|
| Humans | 9 | 2014 | 261506 | 0.060 |
Why?
|
| Multivariate Analysis | 1 | 2012 | 4298 | 0.060 |
Why?
|
| Prevalence | 1 | 2011 | 3260 | 0.060 |
Why?
|
| Disease Progression | 2 | 2011 | 6682 | 0.060 |
Why?
|
| Male | 5 | 2013 | 123000 | 0.060 |
Why?
|
| Genome-Wide Association Study | 1 | 2011 | 2265 | 0.060 |
Why?
|
| Texas | 1 | 2013 | 6311 | 0.050 |
Why?
|
| Adolescent | 2 | 2013 | 31252 | 0.050 |
Why?
|
| Female | 5 | 2013 | 141928 | 0.050 |
Why?
|
| Treatment Outcome | 2 | 2013 | 32848 | 0.050 |
Why?
|
| United States | 3 | 2012 | 15433 | 0.050 |
Why?
|
| Infant | 2 | 2012 | 13310 | 0.040 |
Why?
|
| Survival Rate | 1 | 2012 | 12221 | 0.040 |
Why?
|
| Child, Preschool | 2 | 2012 | 16273 | 0.040 |
Why?
|
| Time Factors | 1 | 2013 | 12926 | 0.040 |
Why?
|
| Adult | 2 | 2012 | 77950 | 0.030 |
Why?
|
| Gene Expression Regulation, Neoplastic | 1 | 2011 | 8873 | 0.030 |
Why?
|
| Middle Aged | 2 | 2012 | 86204 | 0.030 |
Why?
|
| Retrospective Studies | 2 | 2012 | 37905 | 0.030 |
Why?
|
| Interdisciplinary Communication | 1 | 2011 | 280 | 0.020 |
Why?
|
| Cooperative Behavior | 1 | 2011 | 313 | 0.020 |
Why?
|
| Liver Cirrhosis | 1 | 2011 | 941 | 0.020 |
Why?
|
| Neoplasm Invasiveness | 1 | 2011 | 3981 | 0.010 |
Why?
|
| Liver | 1 | 2011 | 2961 | 0.010 |
Why?
|
| Genetic Predisposition to Disease | 1 | 2011 | 5539 | 0.010 |
Why?
|
| Neoplasm Recurrence, Local | 1 | 2011 | 10035 | 0.010 |
Why?
|